Ki Summary

Reaction Details

Report a problem with these data

Target

B2 bradykinin receptor

Ligand

BDBM50045220

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_40423 (CHEMBL652638)

550±n/a nM

Citation

Salvino, JM; Seoane, PR; Douty, BD; Awad, MM; Dolle, RE; Houck, WT; Faunce, DM; Sawutz, DG Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor. J Med Chem36:2583-4 (1993) [PubMed]

More Info.:

Get all data from this article, Assay Method

B2 bradykinin receptor

Name:

B2 bradykinin receptor

Synonyms:

Type:

Enzyme Catalytic Domain

Mol. Mass.:

44467.17

Organism:

Homo sapiens (Human)

Description:

B2 BRADYKININ BDKRB2 HUMAN::P30411

Residue:

391

Sequence:

MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQVEWLGWLNTIQ
PPFLWVLFVLATLENIFVLSVFCLHKSSCTVAEIYLGNLAAADLILACGLPFWAITISNN
FDWLFGETLCRVVNAIISMNLYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLV
IWGCTLLLSSPMLVFRTMKEYSDEGHNVTACVISYPSLIWEVFTNMLLNVVGFLLPLSVI
TFCTMQIMQVLRNNEMQKFKEIQTERRATVLVLVVLLLFIICWLPFQISTFLDTLHRLGI
LSSCQDERIIDVITQIASFMAYSNSCLNPLVYVIVGKRFRKKSWEVYQGVCQKGGCRSEP
IQMENSMGTLRTSISVERQIHKLQDWAGSRQ

BDBM50045220

n/a

Name

BDBM50045220

Synonyms:

3-[2-(N',N''-Dicyclohexyl-guanidino)-3-naphthalen-2-yl-propionylamino]-1-azonia-bicyclo[2.2.2]octane; dihydrochloride (diastereomer 1) | 3-[2-(N',N''-Dicyclohexyl-guanidino)-3-naphthalen-2-yl-propionylamino]-1-azonia-bicyclo[2.2.2]octane; dihydrochloride (diastereomer 2) | 3-[2-(N',N''-Dicyclohexyl-guanidino)-3-naphthalen-2-yl-propionylamino]-1-azonia-bicyclo[2.2.2]octane; dihydrochloride (diastereomeric mixture) | CHEMBL444322

Type

Small organic molecule

Emp. Form.

C33H49N5O

Mol. Mass.

531.774

SMILES

O=C(NC1C[NH+]2CCC1CC2)[C@H](Cc1ccc2ccccc2c1)N\C(NC1CCCCC1)=[NH+]\C1CCCCC1 |wD:11.26,(26.63,-13.75,;26.66,-15.29,;28,-16.02,;29.32,-15.26,;29.32,-16.79,;30.57,-17.79,;30.01,-16.46,;31.01,-15.83,;30.63,-14.48,;31.98,-15.26,;31.98,-16.79,;25.28,-15.95,;25.22,-18.04,;23.73,-19.54,;23.73,-21.09,;22.4,-21.85,;21.07,-21.09,;19.74,-21.85,;18.42,-21.09,;18.4,-19.54,;19.74,-18.77,;21.07,-19.55,;22.4,-18.77,;24,-15.06,;22.49,-15.35,;22.05,-16.83,;20.51,-16.81,;19.54,-18.32,;17.59,-17.49,;16.19,-17.88,;17.17,-16.38,;19.02,-17.21,;21.31,-13.91,;19.77,-13.85,;18.27,-14.25,;16.41,-13.4,;15.45,-14.9,;16.85,-14.52,;18.78,-15.35,)|

Structure